investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
SPORE in Cervical Cancer - Project 3: Treatment of HIV- and HIV+ Patients With HPV16+ CIN2/3 Using pNGLVa-hCRTE6E7L2 DNA Vaccine Administered Intramuscularly Via Electroportation
Chien-Fu Hung
0 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Chien-Fu Hung
Johns Hopkins University
Baltimore, United States
Related projects
Jose Jeronimo
Cervical Cancer Screening and Precancer Treatment
Cervix uteri
Tzyy-Choou Wu
Enhancing HPV-16 E6/E7 Specific Antitumor Immunity
Cervix uteri
E. Blair Holladay
Partners for Cancer Diagnostic and Treatment in Africa
Cervix uteri
Pathology
Charles Wood
Fogarty International Training Program in HIV- and AIDS-Associated Malignancies
Cervix uteri
Melinda Sue Butschkovacic
Fanconi Anemia as a Model for Susceptibility to Human Papillomavirus Infection
Cervix uteri
Tzyy-Choou Wu
SPORE in Cervical Cancer - Project 5: A Phase I Safety and Immunogenicity Study of a HP16- Specific Therapeutic Protein, TA-CIN, Administered Intratumorally During Chemoradiation, in Patients with Inoperable HPV16+ Cervical Cancer
Cervix uteri
Radiation Oncology
Corey Casper
Uganda Cancer Institute / Hutchinson Center Cancer Alliance (UCI/HCCA)
Cervix uteri
Richard Roden
SPORE in Cervical Cancer - Project 2: Local TA-CIN/GPI-0100 Vaccination and Imiquimod for Persistent HPV16+/Normal Cytology Patients
Cervix uteri
Tzyy-Choou Wu
SPORE in Cervical Cancer - Master
Cervix uteri
